tiprankstipranks
Immunome (IMNM)
NASDAQ:IMNM
US Market

Immunome (IMNM) Ownership - Who Owns Immunome?

183 Followers

Immunome (IMNM) Ownership Overview

5.52%15.89%9.61%68.98%
9.61% Other Institutional Investors
68.98% Public Companies and
Individual Investors
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail and individual investors. Approximately 25.50% of the company’s stock is owned by Institutional Investors, 5.52% is owned by Insiders and 68.98% is owned by Public Companies and Individual Investors.
The ownership structure of Immunome (IMNM) stock is a mix of institutional, retail and individual investors. Approximately 25.50% of the company’s stock is owned by Institutional Investors, 5.52% is owned by Insiders and 68.98% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
May 22, 2024
xxxxxxxxxxxxx
$27120
May 21, 2024
Clay Siegall
President & Ceo,director
xxxxxxxxxxxxx
$1387344
Oct 04, 2023
Clay Siegall
President & Ceo,director
xxxxxxxxxxxxx
$999996
Oct 04, 2023
Bruce Turner
Chief Strategy Officer
xxxxxxxxxxxxx
$249993

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
2,148,729Institution3.58%30,060,719
2,088,655Institution3.48%29,220,283
2,021,414Institution3.37%28,279,582
1,923,351Institution3.21%26,907,680
1,493,360Institution2.49%20,892,106
1,318,056Institution2.20%18,439,603
1,247,736Institution2.08%17,455,827
739,382Institution1.23%10,343,954
594,000Institution0.99%8,310,060
467,675Institution0.78%6,542,773

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,021,414Institution3.37%28,279,582
1,923,351Institution3.21%26,907,680
1,493,360Institution2.49%20,892,106
739,382Institution1.23%10,343,954
467,675Institution0.78%6,542,773
433,912Institution0.72%6,070,429
376,813Institution0.63%5,271,614
324,093Institution0.54%4,534,061
251,272Institution0.42%3,515,295
218,383Institution0.36%3,055,178

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,301,158Institution2.17%19,439,301
1,378,784Institution2.30%19,289,188
1,169,031Institution1.95%17,137,994
603,847Institution1.01%9,021,474
458,531Institution0.76%6,414,849
130,725Institution0.22%1,953,032
116,310Institution0.19%1,627,177
62,303Institution0.10%871,619
52,925Institution0.09%775,881
47,487Institution0.08%664,343

FAQ

Who Owns Immunome (IMNM)?
According to the latest TipRanks data, approximately 9.61% of the company's stock is held by institutional investors, 5.52% is held by insiders, and 68.98% is held by retail investors.
    What percentage of Immunome (IMNM) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 9.61% of Immunome (IMNM) stock is held by institutional investors.
      What percentage of Immunome (IMNM) stock is held by retail investors?
      According to the latest TipRanks data, approximately 68.98% of Immunome (IMNM) stock is held by retail investors.
        Who owns the most shares of Immunome (IMNM)?
        iShares owns the most shares of Immunome (IMNM).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis